NK

Nitin Kumar

Active Director Director DIN 02415372
DIN 02415372 First appointment Jan 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 1 historical roles
Total affiliations 8 Since Jan 2009
Shareholding value •••• Premium profile

About Nitin Kumar

Data last updated:

Nitin Kumar is a Director at Dawawale Pharmaceuticals Limited (since 2022), Director at Pavitra Kuber Nidhi Limited (since 2019) and Designated Partner at Shubh Sourya Developers Llp (since 2015), and holds 4 more current directorships. The companies operate in Pharma, Service and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹88.2 Lakh; the largest is Dawawale Pharmaceuticals Limited at ₹87.6 Lakh (FY 2023). Earlier, Nitin Kumar was an Additional Director at Olex Infrastructure Private Limited (2019–2021).

DIN 02415372
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2009
Oldest Company Age 17 yrs
Largest company Dawawale Pharmaceuticals Limited · ₹87.6 Lakh (FY 2023)
Combined revenue ₹88.2 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dawawale Pharmaceuticals Limited U24290UP2020PLC134254
Director15 Jul 20222020₹87.6 Lakh (FY 2023)Active
Pavitra Kuber Nidhi Limited U93090BR2017PLC036009
Director20 Aug 20192017₹65,430 (FY 2023)Active
Designated Partner06 May 20152015Active
Royal Nest Homes Private Limited U45200BR2014PTC022927
Director15 Sep 20142014Active
Director08 Nov 20122012Active
Director13 Apr 20092009Under Process Of Striking Off
Director16 Jan 20092009Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olex Infrastructure Private Limited U70102DL2013PTC262755
Additional Director20 Aug 20192013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dawawale Pharmaceuticals Limited
Shubh Sourya Infrastructure Private Limited
Royal Nest Homes Private Limited
Sai Shrinkhala Developers Private Limited
Premium access

Shareholding and investment profile for Nitin Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Kumar

Nitin Kumar currently holds 7 directorships: Dawawale Pharmaceuticals Limited (Director, since 15 Jul 2022, revenue ₹87.6 Lakh (FY 2023)); Pavitra Kuber Nidhi Limited (Director, since 20 Aug 2019, revenue ₹65,430 (FY 2023)); Shubh Sourya Developers Llp (Designated Partner, since 06 May 2015); Royal Nest Homes Private Limited (Director, since 15 Sep 2014); Sai Shrinkhala Developers Private Limited (Director, since 08 Nov 2012); and 2 more.

Nitin Kumar was first appointed on 16 Jan 2009 as Director at Shubh Sourya Infrastructure Private Limited. The most recent appointment on record is 15 Jul 2022 at Dawawale Pharmaceuticals Limited.

The 2 current companies of Nitin Kumar that report revenue have a combined latest revenue of ₹88.2 Lakh: Dawawale Pharmaceuticals Limited ₹87.6 Lakh (FY 2023); Pavitra Kuber Nidhi Limited ₹65,430 (FY 2023).

Nitin Kumar held 1 earlier board appointment: Olex Infrastructure Private Limited (Additional Director, 20 Aug 2019 to 01 Nov 2021).

The current boards of Nitin Kumar's companies include Gopal Prasad Sinha (Dawawale Pharmaceuticals Limited), Nilam Sinha (Dawawale Pharmaceuticals Limited), Bhawna Sinha (Pavitra Kuber Nidhi Limited), Ruma Sinha (Pavitra Kuber Nidhi Limited), Kumar Gaurav (Shubh Sourya Developers Llp), Mohammad Zeyaullah (Shubh Sourya Developers Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available